无码福利在线观看1000集,久久精品人妻少妇一区二区三区 ,99精品免视看

產品展示

產品詳情

查看大圖

產品名稱：重組人可溶性Fas受體/ TNFRSF6蛋白
產品型號：rHusFasR/TNFRSF6
產品廠商：KALANG
產品文檔：

你添加了1件商品查看購物車

簡單介紹：

重組人可溶性Fas受體/ TNFRSF6蛋白與其它公司提供的重組蛋白不同，rHusFasR/TNFRSF6蛋白產品為采用CFS的無細胞麥胚蛋白合成系統表達出來的重組蛋白，可表達出對細胞有毒性、易被蛋白酶降解的蛋白；并獲得具有良好的可溶性，并有翻譯后修飾、從而部分具有功能的蛋白.同時獨有的全自動蛋白純化技術則簡便高效，將蛋白純化過程中對蛋白的損傷降低到*小程度.重組人可溶性Fas受體/ TNFRSF6蛋白（全長序列）產品可用于Western Blot驗證、抗體制備、蛋白檢測、ELISA等試驗中.

詳情介紹：

重組人可溶性Fas受體/ TNFRSF6蛋白

Synonyms TNFRSF6, CD95, Apo I, Fas Antigen

Species Human

Accession P25445

GeneID 355

Source Escherichia coli.

Molecular Weight 重組人可溶性Fas受體/ TNFRSF6蛋白Approximately 17.6 kDa, a single non-glycosylated polypeptide chain containing 157 amino acids.

Quantity 5μg/20μg/1000μg

AA Sequence RLSSKSVNAQ VTDINSKGLE LRKTVTTVET QNLEGLHHDG QFCHKPCPPG ERKARDCTVN GDEPDCVPCQ EGKEYTDKAH FSSKCRRCRL CDEGHGLEVE INCTRTQNTK CRCKPNFFCN STVCEHCDPC TKCEHGIIKE CTLTSNTKCK EEGSRSN

Purity > 95 % by SDS-PAGE and HPLC analyses.

Biological Activity 重組人可溶性Fas受體/ TNFRSF6蛋白Fully biologically active when compared to standard. The ED₅₀ as determined by its ability to inhibit the cytotoxicity of Jurkat cells is between 10-15 μg/ml in the presence of 2 ng/ml of rHuFas Ligand.

Physical Appearance Sterile Filtered White lyophilized (freeze-dried) powder.

Formulation Lyophilized from a 0.2 μm filtered concentrated solution in PBS, pH 7.4.

Endotoxin Less than 1 EU/μg of rHusFasR/TNFRSF6 as determined by LAL method.

Reconstitution 重組人可溶性Fas受體/ TNFRSF6蛋白We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions.

Storage This lyophilized preparation is stable at 2-8 °C, but should be kept at -20 °C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8 °C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20 °C to -70 °C. Avoid repeated freeze/thaw cycles.

重組人可溶性Fas受體/ TNFRSF6蛋白

SDS-PAGE

Reference 1. Zhang W, Ramdas L, Shen W, et al. 2003. Cancer Biol Ther, 2: 572-8.
2. Takubo T, Kumura T, Nishiki S, et al. 2000. Acta Haematol, 103: 165-7.
3. Lautrette C, Loum-Ribot E, Petit D, et al. 2006. Apoptosis, 11: 1195-204.
4. Kovacic N, Grcevic D, Katavic V, et al. 2010. Lab Invest, 90: 402-13.
5. Kaufmann T, Strasser A, Jost PJ. 2012. Cell Death Differ, 19: 42-50.

Background Fas and Fas Ligand (FasL) belong to the TNF superfamily and are type I and type II transmembrane proteins, respectively. Binding of FasL to Fas triggers apoptosis in Fas-bearing cells. The mechanism of apoptosis involves recruitment of pro-caspase 8 through an adaptor molecule called FADD followed by processing of the pro-enzyme to active forms. These active caspases then cleave various cellular substrates leading to the eventual cell death. sFasR is capable of inhibiting FasL-induced apoptosis by acting as a decoy receptor that serves as a sink for FasL.

標題：

內容：

聯系人：

聯系電話：

Email：

公司名稱：

聯系地址：

注：1.可以使用快捷鍵Alt+S或Ctrl+Enter發送信息!

2.如有必要,請您留下您的詳細聯系方式!

滬公網安備 31011702004399號

Synonyms	TNFRSF6, CD95, Apo I, Fas Antigen
Species	Human
Accession	P25445
GeneID	355
Source	Escherichia coli.
Molecular Weight	重組人可溶性Fas受體/ TNFRSF6蛋白Approximately 17.6 kDa, a single non-glycosylated polypeptide chain containing 157 amino acids.
Quantity	5μg/20μg/1000μg
AA Sequence	RLSSKSVNAQ VTDINSKGLE LRKTVTTVET QNLEGLHHDG QFCHKPCPPG ERKARDCTVN GDEPDCVPCQ EGKEYTDKAH FSSKCRRCRL CDEGHGLEVE INCTRTQNTK CRCKPNFFCN STVCEHCDPC TKCEHGIIKE CTLTSNTKCK EEGSRSN
Purity	> 95 % by SDS-PAGE and HPLC analyses.
Biological Activity	重組人可溶性Fas受體/ TNFRSF6蛋白Fully biologically active when compared to standard. The ED₅₀ as determined by its ability to inhibit the cytotoxicity of Jurkat cells is between 10-15 μg/ml in the presence of 2 ng/ml of rHuFas Ligand.
Physical Appearance	Sterile Filtered White lyophilized (freeze-dried) powder.
Formulation	Lyophilized from a 0.2 μm filtered concentrated solution in PBS, pH 7.4.
Endotoxin	Less than 1 EU/μg of rHusFasR/TNFRSF6 as determined by LAL method.
Reconstitution	重組人可溶性Fas受體/ TNFRSF6蛋白We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions.
Storage	This lyophilized preparation is stable at 2-8 °C, but should be kept at -20 °C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8 °C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20 °C to -70 °C. Avoid repeated freeze/thaw cycles.
重組人可溶性Fas受體/ TNFRSF6蛋白
SDS-PAGE
Reference	1. Zhang W, Ramdas L, Shen W, et al. 2003. Cancer Biol Ther, 2: 572-8. 2. Takubo T, Kumura T, Nishiki S, et al. 2000. Acta Haematol, 103: 165-7. 3. Lautrette C, Loum-Ribot E, Petit D, et al. 2006. Apoptosis, 11: 1195-204. 4. Kovacic N, Grcevic D, Katavic V, et al. 2010. Lab Invest, 90: 402-13. 5. Kaufmann T, Strasser A, Jost PJ. 2012. Cell Death Differ, 19: 42-50.
Background	Fas and Fas Ligand (FasL) belong to the TNF superfamily and are type I and type II transmembrane proteins, respectively. Binding of FasL to Fas triggers apoptosis in Fas-bearing cells. The mechanism of apoptosis involves recruitment of pro-caspase 8 through an adaptor molecule called FADD followed by processing of the pro-enzyme to active forms. These active caspases then cleave various cellular substrates leading to the eventual cell death. sFasR is capable of inhibiting FasL-induced apoptosis by acting as a decoy receptor that serves as a sink for FasL.

天堂国产一区二区三区丨好湿好紧太硬了我太爽了视频丨日本高清视频在线www色丨免费人成视频丨边喂奶边中出的人妻

產品名稱：重組人可溶性Fas受體/ TNFRSF6蛋白